Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in J Int Neuropsychol Soc

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    March 2018
  1. BUONOCORE M, Bechi M, Uberti P, Spangaro M, et al
    Cognitive Reserve Profiles in Chronic Schizophrenia: Effects on Theory of Mind Performance and Improvement after Training.
    J Int Neuropsychol Soc. 2018 Mar 20:1-9. doi: 10.1017/S1355617718000012.
    PubMed     Text format     Abstract available


    January 2018
  2. BRYCE SD, Rossell SL, Lee SJ, Lawrence RJ, et al
    Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial.
    J Int Neuropsychol Soc. 2018 Jan 21:1-14. doi: 10.1017/S1355617717001369.
    PubMed     Text format     Abstract available


    October 2017
  3. LEWANDOWSKI KE, Baker JT, McCarthy JM, Norris LA, et al
    Reproducibility of Cognitive Profiles in Psychosis Using Cluster Analysis.
    J Int Neuropsychol Soc. 2017 Oct 18:1-9. doi: 10.1017/S1355617717001047.
    PubMed     Text format     Abstract available


  4. OKRUSZEK L, Piejka A, Szczepocka E, Wysokinski A, et al
    Affective and Cognitive Verbal Theory of Mind in Schizophrenia: Results From a Novel Paradigm.
    J Int Neuropsychol Soc. 2017 Oct 17:1-5. doi: 10.1017/S1355617717000960.
    PubMed     Text format     Abstract available


  5. SEIDMAN LJ, Mirsky AF
    Evolving Notions of Schizophrenia as a Developmental Neurocognitive Disorder.
    J Int Neuropsychol Soc. 2017;23.
    PubMed     Text format     Abstract available


    June 2017
  6. FRAJO-APOR B, Kemmler G, Pardeller S, Huber M, et al
    Is Emotional Intelligence Impaired in Unaffected Siblings of Patients with Schizophrenia?
    J Int Neuropsychol Soc. 2017 Jun 13:1-7. doi: 10.1017/S135561771700042.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: